MedTrace Logo

Study Using the SpinalStim Device Following Lumbar Fusion Surgery

NCT03176303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2022-09-16

No results posted yet for this study

Summary

This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.

Conditions

  • Lumbar Spine Degeneration

Interventions

DEVICE

SpinalStim

PEMF osteogenesis stimulator

Sponsors & Collaborators

  • Orthofix Inc.

    lead INDUSTRY

Principal Investigators

  • James T Ryaby, Ph.D. · Orthofix Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2021-07-12
Completion
2021-07-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176303 on ClinicalTrials.gov